Brain Structure and Function Associated with Younger Adults in Growth Hormone Receptor-Deficient Humans.
Level 4 - case-series / case-control
Case-control observational study comparing individuals with a rare genetic condition to unaffected familial controls.
PubMed 28073935 · doi:10.1523/JNEUROSCI.1929-16.2016
What was done
Researchers used structural and functional MRI along with cognitive testing to compare 13 individuals with growth hormone receptor deficiency (GHRD) against 12 unaffected relative controls in an Ecuadorian population. The assessment evaluated white matter microstructural integrity, total and subregional hippocampal volumes, cortical thickness and surface area, resting-state default mode network connectivity, and brain activation during a hippocampal-dependent pattern separation task.
What was found
The abstract reports no numerical values, confidence intervals, or exact p-values. Directionally, the GHRD group showed: - Larger surface areas in several frontal and cingulate regions. - Trends toward larger dentate gyrus and CA1 subregions of the hippocampus. - Lower mean diffusivity in the genu of the corpus callosum and anterior thalamic tracts. - Enhanced cognitive and memory performance. - Greater task-related activation in frontal, parietal, and hippocampal regions. - Greater functional synchronicity between the precuneus and the rest of the default mode network at rest.
Why it matters
While GHRD was previously known to protect against age-related metabolic diseases and cancer, this study provides the first human evidence that growth hormone receptor deficiency is associated with preserved brain structure, functional connectivity, and cognitive performance.
Limits
The study is constrained by a very small sample size (13 cases and 12 controls) and a cross-sectional design that cannot measure longitudinal cognitive aging trajectories. Findings in this specific genetic cohort may not generalize broadly, and the abstract omits quantitative effect sizes and variance measures.
Cited by
- supports Individuals in Ecuador with growth hormone receptor deficiency (Laron syndrome) are protected from cancer, diabetes, and age-dependent cognitive decline.